The human genome project: Assessing confidence in knowledge and training requirements for community pharmacists

被引:21
作者
Sansgiry, SS [1 ]
Kulkarni, AS [1 ]
机构
[1] Univ Houston, Coll Pharm, Dept Clin Sci & Adm, Texas Med Ctr, Houston, TX 77030 USA
关键词
Human Genome Project; genetic testing; pharmacogenomics; knowledge; community pharmacists;
D O I
10.5688/aj670239
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Objectives. This study evaluated community pharmacists' confidence in their knowledge regarding the advances in the human genome project (HGP) and determined their requirements for education and training on this subject. Methods. A survey was administered to community pharmacists (N=377) working in the Houston Metropolitan Area using a convenient sampling process. Results. In general, respondents indicated that their confidence in knowledge regarding the HGP, genetic testing, and pharmacogenomics was less than 50%. Overall, pharmacists believe that they should receive training on the proper handling of drugs developed from the advances in the HGP. In addition, they agreed that pharmacists should be required to take at least 2 CE credits on human genetics and that pharmacy schools should include information regarding the advances in the HGP in their curriculum. Conclusions. Pharmacist should be educated in the advances of the HGP and the implications of such advances on their professional responsibilities. Colleges of pharmacy across the nation should explore ways to incorporate information regarding the HGP in their curriculums. Furthermore, opportunities to provide continuing education (CE) credits should be explored by various pharmacy organizations.
引用
收藏
页数:10
相关论文
共 30 条
[1]  
*AM PHARM ASS, 1999 2000 POL COMM R
[2]  
*AM SOC HLTH SYST, COUNC PROF AFF POL R
[3]   Continuing-education programs in pharmacogenomics for pharmacists [J].
Brock, TP ;
Faulkner, CM ;
Williams, DM ;
Smith, SR .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (08) :722-725
[4]  
Carrico J M, 2000, J Am Pharm Assoc (Wash), V40, P115
[5]  
Cassady JM, 1998, AM J HEALTH-SYST PH, V55, P2519
[6]  
CIPPOLE RJ, 1996, PHARM CARE PRACTICE, P95
[7]   New goals for the US Human Genome Project: 1998-2003 [J].
Collins, FS ;
Patrinos, A ;
Jordan, E ;
Chakravarti, A ;
Gesteland, R ;
Walters, L ;
Fearon, E ;
Hartwelt, L ;
Langley, CH ;
Mathies, RA ;
Olson, M ;
Pawson, AJ ;
Pollard, T ;
Williamson, A ;
Wold, B ;
Buetow, K ;
Branscomb, E ;
Capecchi, M ;
Church, G ;
Garner, H ;
Gibbs, RA ;
Hawkins, T ;
Hodgson, K ;
Knotek, M ;
Meisler, M ;
Rubin, GM ;
Smith, LM ;
Smith, RF ;
Westerfield, M ;
Clayton, EW ;
Fisher, NL ;
Lerman, CE ;
McInerney, JD ;
Nebo, W ;
Press, N ;
Valle, D .
SCIENCE, 1998, 282 (5389) :682-689
[8]  
ENSOM MHH, 2001, CAN J HOSP PHARM, V54, P6
[9]   THE HUMAN GENOME PROJECT - ANSWERS CLOSER THAN YOU THINK [J].
FORSDYKE, DR .
FASEB JOURNAL, 1990, 4 (14) :3261-3261
[10]   Pharmacogenomics and infectious diseases: Impact on drug response and applications to disease management [J].
Hayney, MS .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (17) :1626-1631